LEE DANNER & BASS INC - NORTHWEST BIOTHERAPEUTICS IN ownership

NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 13 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LEE DANNER & BASS INC ownership history of NORTHWEST BIOTHERAPEUTICS IN
ValueSharesWeighting
Q3 2023$18
+63.6%
20,0000.0%0.00%
+100.0%
Q2 2023$11
-8.3%
20,0000.0%0.00%0.0%
Q1 2023$12
-25.0%
20,0000.0%0.00%
-50.0%
Q4 2022$16
-99.9%
20,0000.0%0.00%
+100.0%
Q3 2022$14,000
+7.7%
20,0000.0%0.00%0.0%
Q2 2022$13,000
-7.1%
20,0000.0%0.00%0.0%
Q1 2022$14,0000.0%20,0000.0%0.00%0.0%
Q4 2021$14,000
-46.2%
20,0000.0%0.00%
-50.0%
Q3 2021$26,000
-10.3%
20,0000.0%0.00%
-33.3%
Q2 2021$29,000
-3.3%
20,0000.0%0.00%0.0%
Q1 2021$30,0000.0%20,0000.0%0.00%0.0%
Q4 2020$30,000
+100.0%
20,0000.0%0.00%
+50.0%
Q3 2020$15,000
+114.3%
20,0000.0%0.00%
+100.0%
Q2 2020$7,000
+133.3%
20,0000.0%0.00%
Q1 2020$3,000
-25.0%
20,0000.0%0.00%
Q4 2019$4,000
-20.0%
20,0000.0%0.00%
-100.0%
Q3 2019$5,0000.0%20,0000.0%0.00%0.0%
Q2 2019$5,0000.0%20,0000.0%0.00%0.0%
Q1 2019$5,000
+25.0%
20,0000.0%0.00%
Q4 2018$4,0000.0%20,0000.0%0.00%
Q3 2018$4,000
-20.0%
20,0000.0%0.00%
-100.0%
Q2 2018$5,0000.0%20,0000.0%0.00%0.0%
Q1 2018$5,0000.0%20,0000.0%0.00%0.0%
Q4 2017$5,000
+25.0%
20,0000.0%0.00%
Q3 2017$4,00020,0000.00%
Other shareholders
NORTHWEST BIOTHERAPEUTICS IN shareholders Q2 2021
NameSharesValueWeighting ↓
Moloney Securities Asset Management, LLC 352,660$320,8150.06%
Opus Capital Group, LLC 60,150$550.01%
AlphaMark Advisors, LLC 14,007$130.01%
ADVISORS MANAGEMENT GROUP INC /ADV 10,270$90.00%
LEE DANNER & BASS INC 20,000$180.00%
Williams Jones Wealth Management, LLC. 44,000$40,0270.00%
MAI Capital Management 20,000$18,1940.00%
Bartlett & Co. LLC 4,292$40.00%
Coston, McIsaac & Partners 1,000$00.00%
View complete list of NORTHWEST BIOTHERAPEUTICS IN shareholders